VQ Biomedical

Website

VQ Biomedical, Inc.

21 Investors
Medical Devices
APEX, NC

VQ Biomedical, Inc. is a pioneering medical device company specializing in advanced healthcare solutions for patients suffering from acute respiratory distress syndrome (ARDS) and other severe lung injuries. By developing innovative technologies, the company aims to improve patient outcomes and enhance the quality of care provided in critical health situations.

Products & Team

Minimally Invasive Central Venous Catheter

Medical DeviceSeed

This innovative catheter is designed to administer supplemental oxygen directly into the bloodstream of patients with severe lung injury. It offers a novel approach to treating conditions where mechanical ventilation and ECMO are traditionally used.

Value Proposition

This product addresses the limitations of existing treatments for ARDS by providing a safer, cost-effective alternative that minimizes the risks associated with current invasive methods.

Pain Points

Current treatments, such as mechanical ventilation and ECMO, can be costly, invasive, and present substantial risks to patients, creating a critical need for safer alternatives.

Minimally invasive designDirect oxygen delivery to the bloodstreamFacilitates lung healing by allowing them to rest
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
APEX, NC
Primary headquarters

Funding History

Total Raised:
$1.6M
E

Debt Financing Offering

Closed
July 2024
$1.6M
Raised
Use of Proceeds
None other than in the ordinary course of business.
Progress
100%
Raised
$1.6M
Target
$1.6M
#000206202925000001